Are you Daniel P. Mirda, M.D.? This profile is yours to edit: update your address, phone, photo and services.
Edit this profileAt a glance
- 1100 Trancas St Ste 256, Napa, CA 94558
About Dr. Mirda
Based in Napa, CA, Daniel P. Mirda, M.D. is listed in the NPI registry under medical oncology. Daniel graduated from Stanford University School of Medicine in 1984. Daniel is also listed as specializing in hematology and hematology & oncology. Medicare claims data shows Daniel provided 27,801 services to 1,185 patients. The services billed most often include injection, darbepoetin alfa, 1 microgram (non-esrd use), injection, denosumab, 1 mg, and established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more. NPI 1811963317 identifies this record in the national registry.
Factual summary compiled by Guide.md from public records; not written by this provider.
Education & Training
Specialty
Credentials & Licensing
Medicare information
Exactly as CMS reports it (National Downloadable File, Opt-Out Affidavits, Order & Referring). Not an insurance directory; confirm coverage with the office.
Contact Information
- (707) 253-7161
- Email not available
Practice Locations
1100 TRANCAS ST STE 256
Napa, CA 94558
Conditions Commonly Evaluated or Treated
Within Medical Oncology generally. Availability varies by clinician, training and location — this profile has not been claimed, so nothing here is a personal claim by the provider.
Conditions
Most searched conditions
- Anemia
- Blood clots
- Breast cancer
- Colon cancer
- Iron-deficiency anemia
- Leukemia
- Lung cancer
- Lymphoma
- Prostate cancer
Abdominal cancer
- Peritoneal Cancer
Blood cancer
- Blood Cancer
Blood disorders
- Low Platelets
- Low White Blood Cell Count
- Multiple Myeloma
- Myelodysplastic Syndrome
- Thick Blood
Cancer complications
- High calcium from cancer
Chest cancer
Complications
- Abdominal fluid swelling from cancer
- Fluid around lungs from cancer
Digestive cancer
- Appendix cancer
- Gallbladder cancer
Digestive cancers
Endocrine cancer
- Adrenal Tumors in Children
Endocrine cancers
Eye cancer
General oncology
- Cancer of unknown primary
Genetic risk
- Inherited Cancer Risk
Gynecologic cancer
Gynecologic cancers
Head and neck
Head and neck cancer
- Head and neck cancer
- Oral cavity cancer
- Salivary Gland Cancer
Metastatic cancer
- Cancer Spread to the Lung
Metastatic disease
- Cancer spread to bones
- Cancer that spread to brain
- Cancer that spread to liver
Neurologic cancers
Sarcomas
Skin cancer
Symptom evaluation
- Cancer pain
- Cancer-related fatigue
- Swollen Lymph Nodes
Thoracic cancers
Treatment side effects
- Chemo Rash
- Mouth Sores From Chemo
- Nerve Pain From Chemo
Urologic cancer
- Penile Cancer
Urologic cancers
Procedures & services
Most searched procedures
- Blood transfusion
- Chemotherapy
- Immunotherapy
- Targeted therapy
Cancer treatment care
- Immunotherapy Side Effect Management
- Maintenance Cancer Therapy
Complication management
- Cancer Blood Clot Treatment
Consultations
- Cancer survivorship care
- Integrative oncology consultation
- Post-cancer surveillance scan review
- Pre-Surgery Chemotherapy Consultation
- Preventative Chemotherapy Consultation
- Radiopharmaceutical therapy consultation
- Second Opinion For Cancer
- Stem cell transplant consultation
- Tumor Board Case Review
Diagnostic testing
Diagnostics
- Bone Marrow Biopsy
- Cancer Genetic Testing
- Pathology second opinion for cancer
- Tumor Biomarker Testing
Infusions
- Bone Strengthening Infusion
- Iron Infusion
- IV hydration for cancer patients
- Neurologic infusion treatment
Injections
- Red Blood Cell Booster Shot
- White Blood Cell Booster Injection
Medication management
- Oral cancer medication monitoring
Patient education
- Chemo Teaching And Education
Port and line care
- Central line placement in child
- Chemo port removal
- PICC line care and removal
Procedures
Specialized treatments
- Bladder instillation therapy
- Heated Chemotherapy Consultation
- Hepatic Artery Pump Chemotherapy Consultation
Specialty treatments
- Bone Strengthening Injections For Cancer
- CAR-T Therapy
- Chemo allergy desensitization
- Clinical Trial Screening
- Hormone Therapy For Cancer
- Spinal chemo injection
Supportive care
- Advance Care Planning For Cancer
- Cancer nutrition counseling
- Cancer pain management
- Cancer Rehabilitation Evaluation
- Cancer weight loss management
- Chemo brain treatment
- Chemo nausea treatment
- Cold cap therapy for hair loss
- Fertility Preservation for Teens Before Cancer Treatment
- Hospice care consultation
- Lymphedema evaluation
- Palliative cancer care
Treatment side effects
- Chemo Rash Treatment
Vascular access
- Chemo port flush and care
- Chemo port placement
- PICC line care and flush
Procedures Most Often Billed to Medicare
27,801 services · 1,185 patients · 17 distinct codes
| Procedure | Type | Code | Services | Compared with peers |
|---|---|---|---|---|
| Injection of drug or substance under skin or into muscle | Treatment | 96372 |
284 | More often than most peers in Medical Oncology |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | Treatment | 96402 |
58 | As often as other peers in Medical Oncology |
| Injection, darbepoetin alfa, 1 microgram (non-esrd use) | Drug given | J0881 |
20,180 | More often than most peers in Medical Oncology |
| Injection, denosumab, 1 mg | Drug given | J0897 |
5,220 | As often as other peers in Medical Oncology |
| Leuprolide acetate (for depot suspension), 7.5 mg | Drug given | J9217 |
66 | Less often than most peers in Medical Oncology |
| Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more | Office visit | 99215 |
810 | More than most peers in Medical Oncology |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient' | Billing code | G2211 |
565 | More often than most peers in Medical Oncology |
| Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more | Office visit | 99214 |
201 | As often as other peers in Medical Oncology |
| Telephone medical discussion with physician, 21-30 minutes | Office visit | 99443 |
145 | More than most peers in Medical Oncology |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Office visit | 99233 |
62 | As often as other peers in Medical Oncology |
Source: CMS Medicare public data. Shows how often procedures were billed — not quality of care or patient satisfaction.
Related providers
Connections drawn from the registry and from what providers have told us. A link here is not a referral or an endorsement.
Related specialists at this location 1
Clinically related specialties at the same address — the people this provider most likely works alongside.
Also at this address 4
Providers at the same street address. Each files their own registry entry, so a shared practice often appears under several different names.
More connections — 24 related providers in 3 groups
Trained at Stanford University School of Medicine 8
Other providers in the same specialty who trained at the same institution.
Class of 1984 at Stanford University School of Medicine 8
Providers who graduated from the same medical school in the same year.
Also performs Injection of drug or substance under skin or into muscle 8
Providers in CA who bill this service to Medicare most often.
Common questions
What does Daniel P. Mirda specialize in?
Daniel P. Mirda is an oncologist in Napa, CA. That is the designation recorded for this NPI in the federal registry, where it is listed as “Medical Oncology”.
NPI registry
Where is Daniel P. Mirda located?
Daniel P. Mirda is listed at 1100 Trancas St Ste 256, Napa, CA 94558. Addresses come from the NPI registry and can lag a move, so confirm before travelling.
NPI registry
What is Daniel P. Mirda's phone number?
The number on file is (707) 253-7161. Contact the office directly to confirm availability and scheduling.
NPI registry
What is the NPI for Daniel P. Mirda?
Daniel P. Mirda's National Provider Identifier is 1811963317. It is issued by the Centers for Medicare & Medicaid Services and is unique and permanent — it does not change if they move practice.
NPI registry
Where did Daniel P. Mirda train?
Daniel P. Mirda attended Stanford University School of Medicine, graduating in 1984. This comes from the CMS National Downloadable File.
CMS public data
How much experience does Daniel P. Mirda have?
Daniel P. Mirda has 42 years experience. Calculated from a graduation year of 1984, reported in the CMS National Downloadable File.
CMS public data
What does Daniel P. Mirda do most often?
According to Medicare billing data, Daniel P. Mirda provides treatments such as injection of drug or substance under skin or into muscle and administration of hormonal anti-neoplastic chemotherapy under skin or into muscle, alongside routine visits and testing. This reflects Medicare patients only and is billing volume, not a measure of quality.
Medicare claims
Is Daniel P. Mirda's profile verified?
Not yet. This profile is built from public federal data and has not been confirmed by Daniel P. Mirda. If this is you, claiming it is free.
Guide.md
Guide.md listings do not constitute medical advice or an endorsement.